Melinda Yushak

1.8k total citations
38 papers, 639 citations indexed

About

Melinda Yushak is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Melinda Yushak has authored 38 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Melinda Yushak's work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (7 papers) and Melanoma and MAPK Pathways (6 papers). Melinda Yushak is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (7 papers) and Melanoma and MAPK Pathways (6 papers). Melinda Yushak collaborates with scholars based in United States, France and Ireland. Melinda Yushak's co-authors include Erin Hofstatter, Mary K. Buss, Andrea J. Bullock, Victor C. W. Tsang, Kathy Hancock, Sowmya Pattabhi, Robert H. Gilman, William S. Lane, John Noh and Armando E. González and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Melinda Yushak

36 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melinda Yushak United States	14	191	165	135	121	117	38	639
Thomas L. Sutton United States	15	95 0.5×	292 1.8×	44 0.3×	20 0.2×	218 1.9×	89	757
Chang‐Ping Lin Taiwan	22	70 0.4×	85 0.5×	22 0.2×	10 0.1×	52 0.4×	113	1.5k
Thomas United Kingdom	14	44 0.2×	109 0.7×	23 0.2×	16 0.1×	205 1.8×	67	694
Edwin Carrascal Colombia	16	121 0.6×	280 1.7×	17 0.1×	14 0.1×	223 1.9×	39	621
Federica Sandri Italy	12	153 0.8×	176 1.1×	10 0.1×	10 0.1×	51 0.4×	23	837
Patrícia Matos Brazil	16	36 0.2×	62 0.4×	35 0.3×	5 0.0×	250 2.1×	46	854
Aslihan Gerhold‐Ay Germany	16	26 0.1×	188 1.1×	58 0.4×	16 0.1×	67 0.6×	27	821
José Luís Sandoval Switzerland	14	34 0.2×	302 1.8×	9 0.1×	18 0.1×	41 0.4×	59	763
Shama Virani United States	17	42 0.2×	516 3.1×	32 0.2×	11 0.1×	152 1.3×	41	1.2k
Mark H. Lowitt United States	13	90 0.5×	173 1.0×	26 0.2×	3 0.0×	66 0.6×	24	805

Countries citing papers authored by Melinda Yushak

Since Specialization

Citations

This map shows the geographic impact of Melinda Yushak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Yushak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Yushak more than expected).

Fields of papers citing papers by Melinda Yushak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda Yushak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Yushak. The network helps show where Melinda Yushak may publish in the future.

Co-authorship network of co-authors of Melinda Yushak

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Yushak. A scholar is included among the top collaborators of Melinda Yushak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Yushak. Melinda Yushak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yushak, Melinda, et al.. (2024). Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions. Journal of Clinical Investigation. 134(12). 1 indexed citations

Yeung, Howa, Ragini R. Kudchadkar, David H. Lawson, et al.. (2023). Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy. SHILAP Revista de lepidopterología. 3(6). 100232–100232. 1 indexed citations

Hamid, Omid, Karl D. Lewis, Amy Weise, et al.. (2023). Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post adjuvant PD-1 analysis.. Journal of Clinical Oncology. 41(16_suppl). 9501–9501. 8 indexed citations

Ruffin, Ayana T., Brian M. Olson, Crystal Mallow, et al.. (2023). 629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26^hi T cell in patients with resectable stage III melanoma. SHILAP Revista de lepidopterología. A718–A718. 1 indexed citations

Andtbacka, Robert H.I., Robert H. Pierce, Jean S. Campbell, et al.. (2022). Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma. Cancer Research Communications. 2(8). 904–913. 15 indexed citations

Knochelmann, Hannah M., Susanne L. Linderman, Jessica G. Shantha, et al.. (2022). Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition. Frontiers in Oncology. 12. 836845–836845. 3 indexed citations

Lowe, Michael, Brian M. Olson, Anthony P. Martinez, et al.. (2020). Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.. Journal of Clinical Oncology. 38(15_suppl). 10061–10061. 2 indexed citations

Lawson, David H., et al.. (2020). Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report. Ocular Immunology and Inflammation. 30(2). 330–337. 1 indexed citations

Bilen, Mehmet Asım, et al.. (2019). Using Metaphors to Explain Immunotherapy to Cancer Patients. 1(3). 6–9. 2 indexed citations

10.

Elsayed, Mohammad, David H. Lawson, Ragini R. Kudchadkar, et al.. (2019). Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization. CardioVascular and Interventional Radiology. 43(2). 254–263. 23 indexed citations

11.

Elsayed, Mohammad, David H. Lawson, Ragini R. Kudchadkar, et al.. (2019). 03:18 PM Abstract No. 230 Predictors of overall and progression-free survival in patients with ocular melanoma metastatic to the liver undergoing Y90 radioembolization: a 15-year single-institution experience. Journal of Vascular and Interventional Radiology. 30(3). S103–S103. 1 indexed citations

12.

Gamboa, Adriana C., Michael Lowe, Melinda Yushak, & Keith A. Delman. (2019). Surgical Considerations and Systemic Therapy of Melanoma. Surgical Clinics of North America. 100(1). 141–159. 7 indexed citations

13.

Cassidy, Richard J., Jeffrey M. Switchenko, Melinda Yushak, et al.. (2018). The importance of surgery in scalp angiosarcomas. Surgical Oncology. 27(4). A3–A8. 22 indexed citations

14.

Yushak, Melinda, Gang Han, Sara Bouberhan, et al.. (2016). Patient preferences regarding incidental genomic findings discovered during tumor profiling. Cancer. 122(10). 1588–1597. 35 indexed citations

15.

Bullock, Andrea J., Erin Hofstatter, Melinda Yushak, & Mary K. Buss. (2012). Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care. Journal of Oncology Practice. 8(4). e50–8. 119 indexed citations

16.

Soltys, John, Melinda Yushak, & Yang Mao‐Draayer. (2010). Regulation of neural progenitor cell fate by anandamide. Biochemical and Biophysical Research Communications. 400(1). 21–26. 23 indexed citations

17.

Hancock, Kathy, Someet Narang, Sowmya Pattabhi, et al.. (2007). False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five™ insect cells: Effect of glycosylation. Journal of Immunological Methods. 330(1-2). 130–136. 31 indexed citations

18.

Hancock, Kathy, Sowmya Pattabhi, Melinda Yushak, et al.. (2006). Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Molecular and Biochemical Parasitology. 147(1). 109–117. 108 indexed citations

19.

El‐Masri, Hisham, Moiz Mumtaz, & Melinda Yushak. (2003). Application of physiologically-based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat. Environmental Toxicology and Pharmacology. 16(1-2). 57–71. 20 indexed citations

20.

Parker, Louise V., Melinda Yushak, C. James Martel, & Charles M. Reynolds. (2000). Bacterial Survival in Snow Made from Wastewater. US Army Corps of Engineers: Engineer Research and Development Center (Knowledge Core). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact